What is AETERNUM HEALTH INC's earnings per share (EPS)?

AETERNUM HEALTH INC (AETN) reported diluted earnings per share of -$0.01 for fiscal year 2025. That is unchanged from the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

AETERNUM HEALTH INC Financials

AETN

FY2025 annual

Revenue $204K +212.7% YoY

Net Income -$337K YoY not available

EPS (Diluted) -$0.01 0.0% YoY

Free Cash Flow Not reported for FY2025

Source SEC Filings (10-K/10-Q) Data as of Jun 30, 2026 Currency USD FYE December

AETERNUM HEALTH INC (AETN) reported $204K in revenue for fiscal year 2025, up 212.7% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI AETN FY2025 2026-05-19

Revenue recovery has begun to repair gross economics, but the business still runs under a balance-sheet overhang.

Gross margin flipped from -19.5% to 58.9%, showing the latest sales were no longer loss-making at the gross-profit line and that basic transaction economics improved sharply. At the same time, operating cash burn shrank to -$3K even as current liabilities stood at $1.13M, so the operating model improved faster than the financing burden and balance-sheet repair did not follow the same pace.

Even after the gross-profit swing, below-gross costs still dominate: SG&A plus interest were about $173K, which helps explain why positive gross profit still ended in a net loss of -$337K. That means the main constraint has shifted from weak gross economics to the layer of overhead and financing costs that still sits beneath them.

The balance sheet is extremely compressed: current ratio fell from 0.6x to 0.05x over the last two annual periods. With cash at $0, day-to-day operations appear to rely more on external accommodation than on internally accumulated liquidity, so improvement in the income statement has not yet translated into real financial slack.

Financial Health Signals

Financial health score not available

AETERNUM HEALTH INC does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Altman Z-Score Distress

-115.10

AETERNUM HEALTH INC scores -115.10, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($18.3M) relative to total liabilities ($2.1M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial

3/7

AETERNUM HEALTH INC passes 3 of 7 computable financial strength tests (2 of the nine could not be computed from available data). 1 of 3 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.

Earnings Quality No Cash Backing

N/A

AETERNUM HEALTH INC reported a net loss of $337K while operations used $3K of cash. With neither figure positive, the ratio between the two carries no quality signal.

Interest Coverage At Risk

N/A

AETERNUM HEALTH INC reported an operating loss of $269K against $68K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$204K

YoY+212.7%

AETERNUM HEALTH INC generated $204K in revenue in fiscal year 2025. This represents an increase of 212.7% from the prior year.

Net Income

-$337K

AETERNUM HEALTH INC reported -$337K in net income in fiscal year 2025.

EPS (Diluted)

-$0.01

YoY0.0%

AETERNUM HEALTH INC earned -$0.01 per diluted share (EPS) in fiscal year 2025. That is unchanged from the prior year.

EBITDA

Not reported for fiscal year 2025.

Cash & Balance Sheet

Cash & Debt

AETERNUM HEALTH INC held $0 in cash as of fiscal year 2025; long-term debt is not reported for that period.

Shares Outstanding

49M

YoY+1.5%

AETERNUM HEALTH INC had 49M shares outstanding in fiscal year 2025. This represents an increase of 1.5% from the prior year.

Free Cash Flow

Not reported for fiscal year 2025.

Dividends Per Share

Not reported for fiscal year 2025.

Margins & Returns

Gross Margin

59.0%

YoY+78.5pp

AETERNUM HEALTH INC's gross margin was 59.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is up 78.5 percentage points from the prior year.

Operating Margin

Not shown for fiscal year 2025: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Net Margin

Not shown for fiscal year 2025: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Return on Equity

Not reported for fiscal year 2025.

Capital Allocation

None of these metrics is reported for fiscal year 2025.

AETN Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

AETN annual income statement

Metric	TTM	FY25	FY24	FY23	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12
Revenue	N/A	$204K+212.7%	$65K+223.8%	$20K	$22K+345.6%	$5K	N/A	N/A	N/A	$0	$0	$0	N/A	$48K+25.9%	$38K+153.1%	$15K
Cost of Revenue	N/A	N/A	N/A	$49K	$44K	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	$120K+1044.9%	-$13K+61.5%	-$33K	-$23K	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$110K	$105K+5.5%	$100K-70.3%	$335K	$47K-79.3%	$229K	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Income	-$594K	-$269K	N/A	-$552K	-$259K+15.0%	-$304K	N/A	N/A	N/A	N/A	N/A	N/A	N/A	-$81K+48.1%	-$156K+13.1%	-$179K
Interest Expense	N/A	$68K-2.9%	$70K-13.3%	$81K	$15K	N/A	N/A	N/A	$762	N/A	$1K-30.6%	$2K	N/A	$20K-15.8%	$24K-24.0%	$32K
Income Tax	N/A	N/A	N/A	N/A	N/A	$0	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	$1.3M	-$337K	N/A	-$633K	-$316K	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	-$99K+58.8%	-$240K+6.5%	-$257K
EPS (Diluted)	—	-$0.010.0%	-$0.010.0%	-$0.01	-$0.01+97.2%	-$0.36	$0.00	N/A	N/A	-$0.01+50.0%	-$0.020.0%	-$0.02-200.0%	$0.02+166.7%	-$0.03	N/A	N/A

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Revenue	N/A	$2K-90.4%	$24K+182.0%	$8K+17.2%	$7K-95.7%	$165K+1219.4%	$12K-19.2%	$15K
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$29K
Gross Profit	N/A	-$12K-233.7%	$9K+204.0%	-$9K-52.7%	-$6K-104.5%	$125K+682.3%	-$22K-44.6%	-$15K
SG&A Expenses	$8K-79.9%	$37K+37.9%	$27K-28.2%	$38K+154.1%	$15K-42.3%	$26K-19.5%	$32K+165.0%	$12K
Operating Income	-$271K-126.6%	-$120K-45.2%	-$82K+31.9%	-$121K-36.3%	-$89K-490.2%	$23K	N/A	-$110K
Interest Expense	N/A	$20K+18.9%	$17K0.0%	$17K-1.3%	$17K+1.8%	$17K-0.4%	$17K-1.1%	$17K
Net Income	$1.7M+1333.4%	-$140K-40.7%	-$99K+28.0%	-$138K-30.2%	-$106K-1896.9%	$6K	N/A	-$77K
EPS (Diluted)	$0.03	$0.00	N/A	$0.00	$0.00-100.0%	$0.01	N/A	$0.00

Not reported in any period shown, so not listed: R&D Expenses.

TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.

AETN Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

AETN annual balance sheet

Metric	FY25	FY24	FY23	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12
Total Assets	$55K-16.6%	$65K-78.8%	$308K	$676K+217.5%	$213K+283852.0%	$75-75.1%	$301+2.0%	$295-10.6%	$330+17.9%	$280-32.7%	$416-32.2%	$614-99.7%	$236K-15.1%	$278K-38.7%	$453K
Current Assets	$54K-16.9%	$64K-79.1%	$307K	$675K	N/A	N/A	N/A	$295-10.6%	$330+17.9%	$280-32.7%	$416-32.2%	$614-95.7%	$14K-71.9%	$51K-76.9%	$222K
Cash & Equivalents	$0	$0	$0	$0	$0	$0-100.0%	$301+2.0%	$295-10.6%	$330+17.9%	$280-32.7%	$416-32.2%	$614-94.4%	$11K-5.7%	$12K+140.8%	$5K
Inventory	$37K-16.9%	$45K+551.0%	$7K	$7K	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$0-100.0%	$5K
Accounts Receivable	$984	$0-100.0%	$3K	$50K	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$2.1M+17.9%	$1.7M+13.5%	$1.5M	$1.5M-15.8%	$1.8M-25.7%	$2.4M+1.1%	$2.4M+1.7%	$2.4M+2.6%	$2.3M+2.3%	$2.3M+2.8%	$2.2M+3.9%	$2.1M-13.8%	$2.4M+2.4%	$2.4M+2.8%	$2.3M
Current Liabilities	$1.1M+38.0%	$822K+63.9%	$501K	$358K+2559.3%	$13K-99.4%	$2.4M+1.1%	$2.4M+1.7%	$2.4M+2.6%	$2.3M+2.3%	$2.3M+2.8%	$2.2M+3.9%	$2.1M-13.8%	$2.4M+2.4%	$2.4M+2.8%	$2.3M
Total Equity	-$2.0M-19.3%	-$1.7M-36.7%	-$1.2M	-$892K+44.1%	-$1.6M+34.5%	-$2.4M-1.1%	-$2.4M-1.7%	-$2.4M-2.7%	-$2.3M-2.3%	-$2.3M-2.8%	-$2.2M-3.9%	-$2.1M+4.7%	-$2.2M-4.7%	-$2.1M-12.8%	-$1.9M
Retained Earnings	-$3.3M-11.5%	-$2.9M-18.1%	-$2.5M	-$1.9M+73.4%	-$7.2M-40.5%	-$5.1M-0.5%	-$5.1M-0.8%	-$5.1M-1.2%	-$5.0M-1.1%	-$4.9M-1.3%	-$4.9M-1.7%	-$4.8M+2.1%	-$4.9M-2.1%	-$4.8M-5.3%	-$4.6M

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Total Assets	$1.9M+2472.2%	$75K+37.5%	$55K-26.3%	$74K-48.9%	$145K-20.1%	$182K+177.5%	$65K-10.4%	$73K
Current Assets	$1.9M+3169.7%	$59K+10.2%	$54K-26.7%	$73K-49.3%	$144K-20.2%	$181K+180.2%	$64K-10.6%	$72K
Cash & Equivalents	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	N/A	$39K+4.8%	$37K+102.9%	$18K-3.6%	$19K0.0%	$19K-57.5%	$45K+29.5%	$35K
Accounts Receivable	$0-100.0%	$866-12.0%	$984+16.7%	$843-99.2%	$102K-37.0%	$162K	$0-100.0%	$15K
Total Liabilities	$2.3M+6.2%	$2.1M+4.1%	$2.1M+4.0%	$2.0M+3.5%	$1.9M+3.8%	$1.8M+5.5%	$1.7M+8.2%	$1.6M
Current Liabilities	N/A	$1.2M+7.4%	$1.1M+7.6%	$1.1M+6.8%	$987K+7.6%	$918K+11.7%	$822K+19.1%	$690K
Total Equity	-$341K+83.5%	-$2.1M-3.2%	-$2.0M-5.2%	-$1.9M-7.8%	-$1.8M-6.4%	-$1.7M+1.2%	-$1.7M-9.1%	-$1.5M
Retained Earnings	-$1.7M+49.2%	-$3.4M-4.3%	-$3.3M-3.1%	-$3.2M-4.5%	-$3.0M-3.6%	-$2.9M+0.2%	-$2.9M-5.0%	-$2.8M

Not reported in any period shown, so not listed: Goodwill, Long-Term Debt.

AETN Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

AETN annual cash flow statement

Metric	TTM	FY25	FY24	FY23	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12
Operating Cash Flow	-$1.6M	-$3K+98.1%	-$154K+42.3%	-$267K	-$303K-157.1%	-$118K	N/A	N/A	N/A	N/A	N/A	N/A	N/A	-$138K-88.3%	-$73K+58.5%	-$177K
Investing Cash Flow	N/A	N/A	N/A	N/A	-$50K	$0	$0	$0	$0	$0	$0	$0	N/A	N/A	N/A	N/A
Financing Cash Flow	N/A	N/A	-$113K-120.7%	$547K	$651K+118.0%	$299K	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$137K+71.5%	$80K-55.3%	$179K

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Operating Cash Flow	-$1.5M-2607.9%	-$56K-46.0%	-$39K-208.1%	$36K+95.1%	$18K+199.6%	-$18K-1649.2%	-$1K+86.9%	-$8K
Financing Cash Flow	$2.2M+3576.7%	$60K	N/A	N/A	N/A	N/A	-$1+100.0%	-$24K

Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow, Dividends Paid, Share Buybacks.

AETN Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

AETN annual financial ratios

Metric	FY25	FY24	FY23	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12
Gross Margin	59.0%+78.5pp	-19.5%	-164.2%	-104.3%	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	-132.2%	N/A	-2746.8%	-1160.3%	-6080.7%	N/A	N/A	N/A	N/A	N/A	N/A	N/A	-168.9%	-409.9%	-1193.2%
Net Margin	-165.5%	N/A	-3147.6%	-1416.1%	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	-207.1%	-632.4%	-1712.8%
Return on Assets	-617.9%	N/A	-205.2%	-46.7%	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	-42.0%+44.5pp	-86.5%-29.8pp	-56.7%
Current Ratio	0.050.0x	0.08-0.5x	0.61	1.88	N/A	N/A	N/A	0.000.0x	0.000.0x	0.000.0x	0.000.0x	0.000.0x	0.010.0x	0.02-0.1x	0.10

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Gross Margin	N/A	-530.0%	38.1%	-103.3%	-79.2%-155.4pp	76.1%	-172.5%	-96.4%
Operating Margin	N/A	-5289.8%	-350.0%	-1449.3%	-1245.6%	13.8%	N/A	-712.9%
Net Margin	N/A	-6179.4%	-421.9%	-1652.0%	-1486.3%	3.6%	N/A	-499.9%
Return on Assets	89.3%+275.5pp	-186.2%-4.2pp	-182.0%+4.2pp	-186.2%-113.1pp	-73.0%-76.3pp	3.3%	N/A	-105.7%
Current Ratio	N/A	0.050.0x	0.050.0x	0.07-0.1x	0.15-0.1x	0.20+0.1x	0.080.0x	0.10

Not reported in any period shown, so not listed: Return on Equity, Debt-to-Equity, FCF Margin.

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Gross Margin, Operating Margin, Net Margin.

Note: Shareholder equity is negative (-$2.0M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Note: The current ratio is below 1.0 (0.05), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Where AETERNUM HEALTH INC Ranks

Frequently Asked Questions

What is AETERNUM HEALTH INC's annual revenue?

AETERNUM HEALTH INC (AETN) reported $204K in total revenue for fiscal year 2025. This represents a 212.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is AETERNUM HEALTH INC's revenue growing?

AETERNUM HEALTH INC (AETN) revenue grew by 212.7% year-over-year, from $65K to $204K in fiscal year 2025.

Is AETERNUM HEALTH INC profitable?

No, AETERNUM HEALTH INC (AETN) reported a net income of -$337K in fiscal year 2025.

What is AETERNUM HEALTH INC's gross margin?

AETERNUM HEALTH INC (AETN) had a gross margin of 59.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is AETERNUM HEALTH INC's operating cash flow?

AETERNUM HEALTH INC (AETN) recorded an outflow of $3K in operating cash flow during fiscal year 2025, representing cash used by core business activities.

What are AETERNUM HEALTH INC's total assets?

AETERNUM HEALTH INC (AETN) had $55K in total assets as of fiscal year 2025, including both current and long-term assets.

How many shares does AETERNUM HEALTH INC have outstanding?

AETERNUM HEALTH INC (AETN) had 49M shares outstanding as of fiscal year 2025.

What is AETERNUM HEALTH INC's current ratio?

AETERNUM HEALTH INC (AETN) had a current ratio of 0.05 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

What is AETERNUM HEALTH INC's return on assets (ROA)?

AETERNUM HEALTH INC (AETN) had a return on assets of -617.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

How does AETERNUM HEALTH INC's liquidity compare with its operating cash outflow?

At the end of fiscal year 2025, AETERNUM HEALTH INC (AETN) held $0 in cash, cash equivalents and investments, and reported an operating cash outflow of $3K over that year. Dividing the one by the other, the reported balance equals about 0 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

Why is AETERNUM HEALTH INC's debt-to-equity ratio negative or not reported?

AETERNUM HEALTH INC (AETN) has negative shareholder equity of -$2.0M as of fiscal year 2025, so no debt-to-equity ratio is reported: dividing debt by equity that is not positive produces a number that cannot be read as leverage. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

What is AETERNUM HEALTH INC's Altman Z-Score?

AETERNUM HEALTH INC (AETN) has an Altman Z-Score of -115.10, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is AETERNUM HEALTH INC's Piotroski F-Score?

AETERNUM HEALTH INC (AETN) has a Piotroski F-Score of 3 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are AETERNUM HEALTH INC's earnings high quality?

AETERNUM HEALTH INC (AETN) reported a net loss of $337K while operations used $3K of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can AETERNUM HEALTH INC cover its interest payments?

AETERNUM HEALTH INC (AETN) reported an operating loss of $269K against $68K in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.